Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Movement disorders induced by dopamine blocking agents.

K D Sethi1

  • 1Medical College of Georgia, Augusta, USA.

Seminars in Neurology
|May 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe exacerbation of undiagnosed restless legs syndrome presenting as a movement disorder emergency.

European journal of neurology·2013
Same author

Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.

Brain research·2007
Same author

Efficacy and safety of pramipexole in restless legs syndrome.

Neurology·2006
Same author

Botulinum toxin A during pregnancy: a survey of treating physicians.

Journal of neurology, neurosurgery, and psychiatry·2005
Same author

The role of radiotracer imaging in Parkinson disease.

Neurology·2005
Same author

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

Neurology·2001

Dopamine blocking agents (DBAs) can cause various involuntary movements, often misdiagnosed. Identifying DBAs through thorough history is crucial for effective treatment and prevention of these movement disorders.

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Movement disorders are often linked to dopamine blocking agents (DBAs).
  • DBAs are prescribed for psychiatric conditions and sometimes inappropriately for other ailments.
  • These agents can induce diverse and combined involuntary movements.

Purpose of the Study:

  • To highlight the diagnostic challenges of DBA-induced movement disorders.
  • To emphasize the importance of accurate drug history in diagnosis.
  • To discuss treatment and prevention strategies for these movement disorders.

Main Methods:

  • Comprehensive drug history collection from patients, families, physicians, and pharmacists.
  • Clinical assessment of movement disorders.

Related Experiment Videos

  • Review of treatment outcomes.

    • Main Results:

    • DBA-induced movement disorders can be misdiagnosed, leading to delayed or incorrect treatment.
    • Accurate and comprehensive drug history is essential for correct diagnosis.
    • Treatment success varies, with agent removal or substitution often preferred.

    Conclusions:

    • Accurate diagnosis of DBA-induced movement disorders relies heavily on detailed drug history.
    • Management involves addressing the offending agent, with prevention being key.
    • Further research into consistent symptomatic treatments may be beneficial.